Related Experiment Video
Updated: Jun 14, 2026
07:13
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Improving medication uptake in aboriginal and Torres Strait islander peoples
Patricia M Davidson1, Penny Abbott, Joyce Davison
1Curtin University of Technology, Centre for Cardiovascular and Chronic Care, Curtin Health Innovation Research Institute, 39 Regent Street, Chippendale, New South Wales 2008, Australia. P.Davidson@curtin.edu.au
Heart, Lung & Circulation
|April 2, 2010
Summary
Improving medication adherence for Aboriginal Australians requires addressing socio-economic factors and ensuring subsidized access to medicines. This is crucial for better health outcomes and Closing the Gap.
Area of Science:
- Pharmacology
- Public Health
- Indigenous Health
Background:
- Poor medication adherence negatively impacts health outcomes, particularly for Indigenous populations.
- Cardiovascular pharmacotherapy has strong evidence, but adherence strategies and evidence-based practices need refinement for Indigenous communities.
- Challenges in medication adherence are more pronounced for Indigenous peoples.
Purpose of the Study:
- Identify factors affecting medication adherence in Aboriginal Australians.
- Propose solutions to enhance the quality use of medicines among this population.
Main Methods:
- Utilized the World Health Organization adherence model to categorize adherence barriers.
- Examined barriers across five key domains: health care system, socio-economic factors, therapy, patient, and condition.
Main Results:
- Significant socio-economic disparities exacerbate medication adherence challenges for Aboriginal Australians.
- Initiatives like the Quality Use of Medicines Maximised for Aboriginal and Torres Strait Islander People (QUMAX) Program are vital for promoting adherence.
Conclusions:
- Addressing modifiable factors is essential for improving health outcomes related to medication adherence.
- Subsidized medication access, regardless of location (urban, regional, rural, remote), is a key strategy for Closing the Gap in Indigenous health.
Related Concept Videos
01:27Bioavailability Enhancement: Drug Permeability Enhancement
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
01:21Factors Affecting Drug Response: Overview
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:29Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
01:22Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug absorption...